Amiodarone Hcl



Indications and Reactions:

Role Indications Reactions
Primary
Atrial Fibrillation 40.2%
Ventricular Tachycardia 12.6%
Arrhythmia 7.7%
Product Used For Unknown Indication 7.6%
Drug Use For Unknown Indication 5.0%
Hypertension 4.1%
Atrial Flutter 2.9%
Cardiac Failure 2.7%
Supraventricular Tachycardia 2.1%
Ventricular Fibrillation 1.9%
Ventricular Arrhythmia 1.9%
Prophylaxis 1.6%
Type 2 Diabetes Mellitus 1.4%
Tachyarrhythmia 1.4%
Cardiac Disorder 1.3%
Cardiac Failure Congestive 1.3%
Insomnia 1.2%
Gout 1.1%
Tachycardia 1.0%
Hyperlipidaemia 1.0%
Pulmonary Fibrosis 8.9%
Ventricular Tachycardia 8.2%
Pulmonary Toxicity 8.0%
Hyperthyroidism 7.7%
Drug Interaction 7.0%
Hypothyroidism 6.7%
Weight Decreased 6.0%
Torsade De Pointes 5.4%
Toxicity To Various Agents 5.4%
Tremor 5.1%
Lung Disorder 4.8%
Pneumonia 3.6%
Rhabdomyolysis 3.1%
Dyspnoea 2.9%
Pneumonitis 2.9%
Respiratory Failure 2.9%
Ventricular Fibrillation 2.9%
Vomiting 2.9%
Interstitial Lung Disease 2.8%
Drug Ineffective 2.6%
Secondary
Atrial Fibrillation 22.7%
Drug Use For Unknown Indication 16.1%
Product Used For Unknown Indication 14.5%
Ventricular Tachycardia 11.8%
Hypertension 6.4%
Cardiac Failure 4.2%
Arrhythmia 3.2%
Cardiac Disorder 3.0%
Prophylaxis 2.1%
Cardiac Failure Congestive 2.1%
Thrombosis Prophylaxis 1.9%
Supraventricular Tachycardia 1.8%
Atrial Flutter 1.7%
Insomnia 1.5%
Ill-defined Disorder 1.2%
Pain 1.2%
Cardiac Failure Chronic 1.2%
Aortic Valve Replacement 1.1%
Pneumonia 1.1%
Ventricular Fibrillation 1.1%
Ventricular Tachycardia 16.6%
Blood Bilirubin Increased 12.5%
Torsade De Pointes 6.5%
Syncope 6.1%
Hepatic Steatosis 5.4%
Drug Ineffective 4.7%
Interstitial Lung Disease 4.7%
Renal Failure Acute 4.7%
Rhabdomyolysis 4.7%
Atrial Fibrillation 4.3%
Drug Interaction 4.0%
Pneumonia 3.2%
Vomiting 3.2%
Weight Decreased 3.2%
Renal Failure 2.9%
International Normalised Ratio Increased 2.7%
Paraesthesia 2.7%
Ventricular Fibrillation 2.7%
Hyperthyroidism 2.5%
Hypotension 2.5%
Concomitant
Product Used For Unknown Indication 31.2%
Drug Use For Unknown Indication 26.6%
Atrial Fibrillation 8.6%
Hypertension 6.9%
Cardiac Disorder 2.8%
Coronary Artery Bypass 2.5%
Nuclear Magnetic Resonance Imaging 2.3%
Cardiac Failure 2.1%
Prophylaxis 2.0%
Multiple Myeloma 1.8%
Pain 1.7%
Osteoporosis 1.6%
Arrhythmia 1.6%
Diabetes Mellitus 1.5%
Chronic Obstructive Pulmonary Disease 1.3%
Blood Cholesterol Increased 1.2%
Rheumatoid Arthritis 1.2%
Cardiac Failure Congestive 1.0%
Depression 1.0%
Angiogram 1.0%
Vomiting 10.0%
Weight Decreased 7.3%
Renal Failure Acute 7.2%
Death 6.9%
Pain 6.4%
Ventricular Tachycardia 6.1%
Renal Failure 5.7%
Injury 5.3%
Unevaluable Event 4.9%
Pneumonia 4.6%
Sepsis 4.2%
Weight Increased 4.2%
Atrial Fibrillation 4.1%
Anxiety 3.8%
Fear 3.6%
International Normalised Ratio Increased 3.2%
Syncope 3.2%
Thrombocytopenia 3.2%
Myocardial Infarction 3.1%
Anhedonia 3.0%
Interacting
Drug Use For Unknown Indication 17.2%
Atrial Fibrillation 15.0%
Product Used For Unknown Indication 10.9%
Supraventricular Tachycardia 7.0%
Ventricular Tachycardia 5.9%
Overdose 5.3%
Pneumonia 4.9%
Myocardial Ischaemia 4.7%
Arrhythmia 4.0%
Ill-defined Disorder 3.6%
Lower Respiratory Tract Infection 3.0%
Atrial Flutter 2.6%
Torsade De Pointes 2.6%
Cardiac Failure 2.2%
Immunosuppression 2.2%
Sinus Arrhythmia 2.1%
Antiplatelet Therapy 1.7%
Hyperlipidaemia 1.7%
Renal Failure Chronic 1.7%
Anticoagulant Therapy 1.5%
Drug Interaction 26.1%
Supraventricular Tachycardia 12.7%
Ventricular Fibrillation 9.6%
Torsade De Pointes 5.7%
Electrocardiogram Qt Prolonged 5.1%
Cardiac Arrest 4.5%
Renal Failure 4.5%
Pneumonia 3.2%
Rhabdomyolysis 3.2%
Toxicity To Various Agents 3.2%
Fall 2.5%
Intentional Overdose 2.5%
International Normalised Ratio Increased 2.5%
Sinus Bradycardia 2.5%
Thrombocytopenia 2.5%
Cholelithiasis 1.9%
Hepatic Enzyme Increased 1.9%
Myopathy 1.9%
Myositis 1.9%
Neurotoxicity 1.9%